Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
Johnson JO., Chia R., Miller DE., Li R., Kumaran R., Abramzon Y., Alahmady N., Renton AE., Topp SD., Gibbs JR., Cookson MR., Sabir MS., Dalgard CL., Troakes C., Jones AR., Shatunov A., Iacoangeli A., Al Khleifat A., Ticozzi N., Silani V., Gellera C., Blair IP., Dobson-Stone C., Kwok JB., Bonkowski ES., Palvadeau R., Tienari PJ., Morrison KE., Shaw PJ., Al-Chalabi A., Brown RH., Calvo A., Mora G., Al-Saif H., Gotkine M., Leigh F., Chang IJ., Perlman SJ., Glass I., Scott AI., Shaw CE., Basak AN., Landers JE., Chiò A., Crawford TO., Smith BN., Traynor BJ., FALS Sequencing Consortium; American Genome Center; International ALS Genomics Consortium; and ITALSGEN Consortium None., Smith BN., Ticozzi N., Fallini C., Gkazi AS., Topp SD., Scotter EL., Kenna KP., Keagle P., Tiloca C., Vance C., Troakes C., Colombrita C., King A., Pensato V., Castellotti B., Baas F., Ten Asbroek ALMA., McKenna-Yasek D., McLaughlin RL., Polak M., Asress S., Esteban-Pérez J., Stevic Z., D'Alfonso S., Mazzini L., Comi GP., Del Bo R., Ceroni M., Gagliardi S., Querin G., Bertolin C., van Rheenen W., Rademakers R., van Blitterswijk M., Lauria G., Duga S., Corti S., Cereda C., Corrado L., Sorarù G., Williams KL., Nicholson GA., Blair IP., Leblond-Manry C., Rouleau GA., Hardiman O., Morrison KE., Veldink JH., van den Berg LH., Al-Chalabi A., Pall H., Shaw PJ., Turner MR., Talbot K., Taroni F., García-Redondo A., Wu Z., Glass JD., Gellera C., Ratti A., Brown RH., Silani V., Shaw CE., Landers JE., Dalgard CL., Adeleye A., Soltis AR., Alba C., Viollet C., Bacikova D., Hupalo DN., Sukumar G., Pollard HB., Wilkerson MD., Martinez EM., Abramzon Y., Ahmed S., Arepalli S., Baloh RH., Bowser R., Brady CB., Brice A., Broach J., Campbell RH., Camu W., Chia R., Cooper-Knock J., Ding J., Drepper C., Drory VE., Dunckley TL., Eicher JD., England BK., Faghri F., Feldman E., Floeter MK., Fratta P., Geiger JT., Gerhard G., Gibbs JR., Gibson SB., Glass JD., Hardy J., Harms MB., Heiman-Patterson TD., Hernandez DG., Jansson L., Kirby J., Kowall NW., Laaksovirta H., Landeck N., Landi F., Le Ber I., Lumbroso S., MacGowan DJL., Maragakis NJ., Mora G., Mouzat K., Murphy NA., Myllykangas L., Nalls MA., Orrell RW., Ostrow LW., Pamphlett R., Pickering-Brown S., Pioro EP., Pletnikova O., Pliner HA., Pulst SM., Ravits JM., Renton AE., Rivera A., Robberecht W., Rogaeva E., Rollinson S., Rothstein JD., Scholz SW., Sendtner M., Shaw PJ., Sidle KC., Simmons Z., Singleton AB., Smith N., Stone DJ., Tienari PJ., Troncoso JC., Valori M., Van Damme P., Van Deerlin VM., Van Den Bosch L., Zinman L., Landers JE., Chiò A., Traynor BJ., Angelocola SM., Ausiello FP., Barberis M., Bartolomei I., Battistini S., Bersano E., Bisogni G., Borghero G., Brunetti M., Cabona C., Calvo A., Canale F., Canosa A., Cantisani TA., Capasso M., Caponnetto C., Cardinali P., Carrera P., Casale F., Chiò A., Colletti T., Conforti FL., Conte A., Conti E., Corbo M., Cuccu S., Dalla Bella E., D'Errico E., DeMarco G., Dubbioso R., Ferrarese C., Ferraro PM., Filippi M., Fini N., Floris G., Fuda G., Gallone S., Gianferrari G., Giannini F., Grassano M., Greco L., Iazzolino B., Introna A., La Bella V., Lattante S., Lauria G., Liguori R., Logroscino G., Logullo FO., Lunetta C., Mandich P., Mandrioli J., Manera U., Manganelli F., Marangi G., Marinou K., Marrosu MG., Martinelli I., Messina S., Moglia C., Mora G., Mosca L., Murru MR., Origone P., Passaniti C., Petrelli C., Petrucci A., Pozzi S., Pugliatti M., Quattrini A., Ricci C., Riolo G., Riva N., Russo M., Sabatelli M., Salamone P., Salivetto M., Salvi F., Santarelli M., Sbaiz L., Sideri R., Simone I., Simonini C., Spataro R., Tanel R., Tedeschi G., Ticca A., Torriello A., Tranquilli S., Tremolizzo L., Trojsi F., Vasta R., Vacchiano V., Vita G., Volanti P., Zollino M., Zucchi E.
IMPORTANCE: Juvenile amyotrophic lateral sclerosis (ALS) is a rare form of ALS characterized by age of symptom onset less than 25 years and a variable presentation. OBJECTIVE: To identify the genetic variants associated with juvenile ALS. DESIGN, SETTING, AND PARTICIPANTS: In this multicenter family-based genetic study, trio whole-exome sequencing was performed to identify the disease-associated gene in a case series of unrelated patients diagnosed with juvenile ALS and severe growth retardation. The patients and their family members were enrolled at academic hospitals and a government research facility between March 1, 2016, and March 13, 2020, and were observed until October 1, 2020. Whole-exome sequencing was also performed in a series of patients with juvenile ALS. A total of 66 patients with juvenile ALS and 6258 adult patients with ALS participated in the study. Patients were selected for the study based on their diagnosis, and all eligible participants were enrolled in the study. None of the participants had a family history of neurological disorders, suggesting de novo variants as the underlying genetic mechanism. MAIN OUTCOMES AND MEASURES: De novo variants present only in the index case and not in unaffected family members. RESULTS: Trio whole-exome sequencing was performed in 3 patients diagnosed with juvenile ALS and their parents. An additional 63 patients with juvenile ALS and 6258 adult patients with ALS were subsequently screened for variants in the SPTLC1 gene. De novo variants in SPTLC1 (p.Ala20Ser in 2 patients and p.Ser331Tyr in 1 patient) were identified in 3 unrelated patients diagnosed with juvenile ALS and failure to thrive. A fourth variant (p.Leu39del) was identified in a patient with juvenile ALS where parental DNA was unavailable. Variants in this gene have been previously shown to be associated with autosomal-dominant hereditary sensory autonomic neuropathy, type 1A, by disrupting an essential enzyme complex in the sphingolipid synthesis pathway. CONCLUSIONS AND RELEVANCE: These data broaden the phenotype associated with SPTLC1 and suggest that patients presenting with juvenile ALS should be screened for variants in this gene.